glp-1 neuroinflammation Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment Glucagon-like peptide-1 medicines in neurological
Description
2025 (pp
Participants taking bofanglutide experienced weight loss and improvements in various cardiometabolic risk factors
GLP-1 is a hormone your body already uses to help regulate hunger and satiety
In this article, we explore the role and therapeutic potential of these well-established obesity drug targets
Who qualifies, and what results look like, are individual, and we settle that at the consultation
excess or altered GIP signalling may contribute to obesity
